Gradient Investments LLC Abbott Laboratories Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

A detailed history of Gradient Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gradient Investments LLC holds 276,522 shares of ABT stock, worth $31.6 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

276,522

Previous 272,582 1.45%

Holding current value

$31.6 Million

Previous $28.3 Million 11.31%

% of portfolio

0.83%

Previous 0.81%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$100.07 - $118.13 $394,275 - $465,432	3,940 Added 1.45%	276,522 $31.5 Million
Q2 2024 Jul 18, 2024	BUY	$100.73 - $112.44 $1.69 Million - $1.88 Million	16,748 Added 6.55%	272,582 $28.3 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $183,336 - $202,487	-1,674 Reduced 0.65%	255,834 $29.1 Million
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $1.04 Million - $1.27 Million	11,508 Added 4.68%	257,508 $28.3 Million
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $473,351 - $567,942	4,955 Added 2.06%	246,000 $23.8 Million
Q2 2023 Jul 11, 2023	BUY	$100.78 - $112.29 $1.42 Million - $1.59 Million	14,129 Added 6.23%	241,045 $26.3 Million
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $15.6 Million - $18.4 Million	161,187 Added 245.23%	226,916 $23 Million
Q4 2022 Jan 10, 2023	SELL	$95.06 - $111.52 $266,738 - $312,925	-2,806 Reduced 4.09%	65,729 $0
Q3 2022 Oct 14, 2022	BUY	$96.76 - $112.03 $480,897 - $556,789	4,970 Added 7.82%	68,535 $6.63 Million
Q2 2022 Jul 11, 2022	SELL	$102.07 - $123.37 $406,238 - $491,012	-3,980 Reduced 5.89%	63,565 $6.91 Million
Q1 2022 May 26, 2022	SELL	$114.02 - $139.04 $474,551 - $578,684	-4,162 Reduced 5.8%	67,545 $8 Million
Q4 2021 Jan 12, 2022	BUY	$115.53 - $141.46 $480,604 - $588,473	4,160 Added 6.16%	71,707 $10.1 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $1.39 Million - $1.54 Million	11,921 Added 21.43%	67,547 $7.98 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $358,522 - $422,032	3,389 Added 6.49%	55,626 $6.45 Million
Q1 2021 Apr 21, 2021	BUY	$108.84 - $128.23 $1.55 Million - $1.83 Million	14,252 Added 37.52%	52,237 $6.26 Million
Q4 2020 Jan 08, 2021	SELL	$105.0 - $114.42 $33,075 - $36,042	-315 Reduced 0.82%	37,985 $4.13 Million
Q3 2020 Oct 06, 2020	BUY	$91.64 - $111.29 $531,328 - $645,259	5,798 Added 17.84%	38,300 $4.17 Million
Q2 2020 Jul 10, 2020	BUY	$76.57 - $98.0 $137,060 - $175,420	1,790 Added 5.83%	32,502 $2.97 Million
Q1 2020 Apr 07, 2020	BUY	$62.82 - $91.86 $369,067 - $539,677	5,875 Added 23.65%	30,712 $2.42 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $223,046 - $248,303	2,841 Added 12.92%	24,837 $2.16 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $342,091 - $370,933	4,180 Added 23.46%	21,996 $1.84 Million
Q2 2019 Jul 16, 2019	BUY	$72.88 - $85.0 $793,517 - $925,480	10,888 Added 157.16%	17,816 $1.5 Million
Q1 2019 Apr 11, 2019	BUY	$66.22 - $80.06 $280,574 - $339,214	4,237 Added 157.45%	6,928 $554,000
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $10 Million - $11.4 Million	-153,277 Reduced 98.27%	2,691 $195,000
Q3 2018 Oct 11, 2018	BUY	$60.81 - $73.36 $188,997 - $228,002	3,108 Added 2.03%	155,968 $11.4 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $73,977 - $81,648	-1,285 Reduced 0.83%	152,860 $9.32 Million
Q1 2018 Apr 11, 2018	BUY	$56.27 - $63.62 $428,270 - $484,211	7,611 Added 5.19%	154,145 $9.24 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $129,637 - $138,790	-2,415 Reduced 1.62%	146,534 $8.36 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $7.16 Million - $7.99 Million	148,949	148,949 $7.95 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Abbott Laboratories Transaction History